Cargando…
An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease
BACKGROUND/OBJECTIVES: The objective of this study was to develop approaches to expressing resting energy expenditure (REE) and lean body mass (LM) phenotypes of metabolic disorders in terms of Z-scores relative to their predicted healthy values. SUBJECTS/METHODS: Body composition and REE were measu...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916834/ https://www.ncbi.nlm.nih.gov/pubmed/24281313 http://dx.doi.org/10.1038/ejcn.2013.237 |
_version_ | 1782302768235544576 |
---|---|
author | Watson, L P E Raymond-Barker, P Moran, C Schoenmakers, N Mitchell, C Bluck, L Chatterjee, V K Savage, D B Murgatroyd, P R |
author_facet | Watson, L P E Raymond-Barker, P Moran, C Schoenmakers, N Mitchell, C Bluck, L Chatterjee, V K Savage, D B Murgatroyd, P R |
author_sort | Watson, L P E |
collection | PubMed |
description | BACKGROUND/OBJECTIVES: The objective of this study was to develop approaches to expressing resting energy expenditure (REE) and lean body mass (LM) phenotypes of metabolic disorders in terms of Z-scores relative to their predicted healthy values. SUBJECTS/METHODS: Body composition and REE were measured in 135 healthy participants. Prediction equations for LM and REE were obtained from linear regression and the range of normality by the standard deviation of residuals. Application is demonstrated in patients from three metabolic disorder groups (lipodystrophy, n=7; thyrotoxicosis, n=16; and resistance to thyroid hormone (RTH), n=46) in which altered REE and/or LM were characterised by departure from the predicted healthy values, expressed as a Z-score. RESULTS: REE (kJ/min)=−0.010 × age (years)+0.016 × FM (kg)+0.054 × fat-free mass (kg)+1.736 (R(2)=0.732, RSD=0.36 kJ/min). LM (kg)=5.30 × bone mineral content (kg)+10.66 × height(2) (m)+6.40 (male). LM (kg)=0.20 × fat (kg)+14.08 × height(2) (m)−2.93 (female). (male R(2)=0.55, RSD=3.90 kg; female R(2)=0.59, RSD=3.85 kg). We found average Z-scores for REE and LM of 1.77 kJ/min and −0.17 kg in the RTH group, 5.82 kJ/min and −1.23 kg in the thyrotoxic group and 2.97 kJ/min and 4.20 kg in the LD group. CONCLUSION: This approach enables comparison of data from individuals with metabolic disorders with those of healthy individuals, describing their departure from the healthy mean by a Z-score. |
format | Online Article Text |
id | pubmed-3916834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-39168342014-02-07 An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease Watson, L P E Raymond-Barker, P Moran, C Schoenmakers, N Mitchell, C Bluck, L Chatterjee, V K Savage, D B Murgatroyd, P R Eur J Clin Nutr Original Article BACKGROUND/OBJECTIVES: The objective of this study was to develop approaches to expressing resting energy expenditure (REE) and lean body mass (LM) phenotypes of metabolic disorders in terms of Z-scores relative to their predicted healthy values. SUBJECTS/METHODS: Body composition and REE were measured in 135 healthy participants. Prediction equations for LM and REE were obtained from linear regression and the range of normality by the standard deviation of residuals. Application is demonstrated in patients from three metabolic disorder groups (lipodystrophy, n=7; thyrotoxicosis, n=16; and resistance to thyroid hormone (RTH), n=46) in which altered REE and/or LM were characterised by departure from the predicted healthy values, expressed as a Z-score. RESULTS: REE (kJ/min)=−0.010 × age (years)+0.016 × FM (kg)+0.054 × fat-free mass (kg)+1.736 (R(2)=0.732, RSD=0.36 kJ/min). LM (kg)=5.30 × bone mineral content (kg)+10.66 × height(2) (m)+6.40 (male). LM (kg)=0.20 × fat (kg)+14.08 × height(2) (m)−2.93 (female). (male R(2)=0.55, RSD=3.90 kg; female R(2)=0.59, RSD=3.85 kg). We found average Z-scores for REE and LM of 1.77 kJ/min and −0.17 kg in the RTH group, 5.82 kJ/min and −1.23 kg in the thyrotoxic group and 2.97 kJ/min and 4.20 kg in the LD group. CONCLUSION: This approach enables comparison of data from individuals with metabolic disorders with those of healthy individuals, describing their departure from the healthy mean by a Z-score. Nature Publishing Group 2014-02 2013-11-27 /pmc/articles/PMC3916834/ /pubmed/24281313 http://dx.doi.org/10.1038/ejcn.2013.237 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ |
spellingShingle | Original Article Watson, L P E Raymond-Barker, P Moran, C Schoenmakers, N Mitchell, C Bluck, L Chatterjee, V K Savage, D B Murgatroyd, P R An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease |
title | An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease |
title_full | An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease |
title_fullStr | An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease |
title_full_unstemmed | An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease |
title_short | An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease |
title_sort | approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916834/ https://www.ncbi.nlm.nih.gov/pubmed/24281313 http://dx.doi.org/10.1038/ejcn.2013.237 |
work_keys_str_mv | AT watsonlpe anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT raymondbarkerp anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT moranc anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT schoenmakersn anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT mitchellc anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT bluckl anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT chatterjeevk anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT savagedb anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT murgatroydpr anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT watsonlpe approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT raymondbarkerp approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT moranc approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT schoenmakersn approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT mitchellc approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT bluckl approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT chatterjeevk approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT savagedb approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease AT murgatroydpr approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease |